News Center

位置：

Honors Announcement

Group News

Media Reports

Shisi Pharmaceutical’s Active Pharmaceutical Ingredients Make Their Debut at the Shanghai API Exhibition

Category:

Honors Announcement

发布时间：2018-04-28

【概要描述】 From April 11 to 13, the 80th China API Exhibition was grandly held at the Shanghai International Exhibition Center. Shisi Pharmaceutical Group, exhibiting for the first time with specially designed booths featuring its three subsidiaries—Hebei Guolong, Hebei Guangxiang, and Jiangsu Bosheng—attracted keen attention from a wide range of exhibitors and business visitors. At the group’s striking and sophisticated custom booth, attendees frequently paused to take a closer look; many customers pointed to the prominently displayed key product categories—such as active pharmaceutical ingredients and medical packaging materials—at the top of the booth and asked the reception staff about product details, saying, “I’d like to distribute your products on a wholesale basis—what policies do you offer?” Some customers even eagerly expressed their intention to establish long-term cooperation with us. “From finished dosage forms and active pharmaceutical ingredients to medical packaging…”

From April 11 to 13, the 80th China API Exhibition was grandly held at the Shanghai International Exhibition Center. Shisi Pharmaceutical Group, which made its debut with specially designed booths showcasing its three subsidiaries—Hebei Guolong, Hebei Guangxiang, and Jiangsu Bosheng—attracted keen attention from a wide range of exhibitors and business visitors.

In front of the Group’s striking and sophisticated custom-designed booth, visitors and business partners alike paused to take a closer look. Many customers pointed to the eye-catching displays at the top of the booth—highlighting key product categories such as active pharmaceutical ingredients and medical packaging materials—and eagerly inquired about product details from the reception staff: “I’d like to distribute your products on a wholesale basis—what kind of policies do you offer?” Some even expressed their eagerness to establish long-term partnerships with us. “From finished dosage forms and active pharmaceutical ingredients to medical packaging materials and auxiliary supplies, Shisi Pharmaceutical Group has gradually established a relatively complete pharmaceutical manufacturing system. Thanks to the strong support of our partners and friends, the Company has achieved rapid growth in scale and strength, brand recognition, and foreign trade exports,” said Group leaders Su Xuejun, General Manager; Wu Hengyao, Deputy General Manager; and Li Weimin, Deputy General Manager, as they warmly briefed both new and existing customers and friends on the Company’s achievements.

“This successful participation in the API Expo has set a strong foundation for the Group’s API business to achieve major growth. As Hebei Guangxiang accelerates its development, the company is poised to reach new heights,” said a company official enthusiastically.

Keywords:

Shisi Pharmaceutical Partners with Zhengzhou University to Tackle the Challenge of Natural-Product-Based Anti-Liver Fibrosis

A Company Project Wins First Prize for Provincial Scientific and Technological Progress

Shisi Pharmaceutical Partners with Zhengzhou University to Tackle the Challenge of Natural-Product-Based Anti-Liver Fibrosis

A Company Project Wins First Prize for Provincial Scientific and Technological Progress